Annual Total Liabilities
$3.59 M
+$1.67 M+87.58%
31 December 2023
Summary:
Tenax Therapeutics annual total liabilities is currently $3.59 million, with the most recent change of +$1.67 million (+87.58%) on 31 December 2023. During the last 3 years, it has risen by +$1.34 million (+59.89%). TENX annual total liabilities is now -71.45% below its all-time high of $12.56 million, reached on 31 December 2015.TENX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$2.56 M
+$820.90 K+47.16%
30 September 2024
Summary:
Tenax Therapeutics quarterly total liabilities is currently $2.56 million, with the most recent change of +$820.90 thousand (+47.16%) on 30 September 2024. Over the past year, it has increased by +$1.96 million (+325.39%). TENX quarterly total liabilities is now -81.97% below its all-time high of $14.21 million, reached on 31 March 2016.TENX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TENX Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +87.6% | +325.4% |
| 3 y3 years | +59.9% | +53.1% |
| 5 y5 years | +129.1% | +107.0% |
TENX Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +105.2% | -28.6% | +325.4% |
| 5 y | 5 years | at high | +129.1% | -28.6% | +325.4% |
| alltime | all time | -71.5% | >+9999.0% | -82.0% | >+9999.0% |
Tenax Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.56 M(+47.2%) |
| June 2024 | - | $1.74 M(-14.3%) |
| Mar 2024 | - | $2.03 M(-43.4%) |
| Dec 2023 | $3.59 M(+87.6%) | $3.59 M(+495.6%) |
| Sept 2023 | - | $602.20 K(-26.9%) |
| June 2023 | - | $823.80 K(-17.1%) |
| Mar 2023 | - | $993.90 K(-48.0%) |
| Dec 2022 | $1.91 M(+9.4%) | $1.91 M(+143.5%) |
| Sept 2022 | - | $785.20 K(-50.0%) |
| June 2022 | - | $1.57 M(-26.3%) |
| Mar 2022 | - | $2.13 M(+22.0%) |
| Dec 2021 | $1.75 M(-22.1%) | $1.75 M(+4.5%) |
| Sept 2021 | - | $1.67 M(+18.3%) |
| June 2021 | - | $1.41 M(-3.5%) |
| Mar 2021 | - | $1.46 M(-34.7%) |
| Dec 2020 | $2.24 M(-13.5%) | $2.24 M(+40.8%) |
| Sept 2020 | - | $1.59 M(-31.5%) |
| June 2020 | - | $2.32 M(-8.4%) |
| Mar 2020 | - | $2.54 M(-2.2%) |
| Dec 2019 | $2.59 M(+65.6%) | $2.59 M(+109.5%) |
| Sept 2019 | - | $1.24 M(+18.6%) |
| June 2019 | - | $1.04 M(-6.6%) |
| Mar 2019 | - | $1.12 M(-28.7%) |
| Dec 2018 | $1.57 M(+55.2%) | $1.57 M(+203.3%) |
| Sept 2018 | - | $516.20 K(-34.9%) |
| June 2018 | - | $792.80 K(+154.9%) |
| Mar 2018 | - | $311.00 K(-69.2%) |
| Dec 2017 | $1.01 M(-83.7%) | $1.01 M(+20.3%) |
| Sept 2017 | - | $838.60 K(-61.6%) |
| June 2017 | - | $2.18 M(-56.7%) |
| Mar 2017 | - | $5.04 M(-18.7%) |
| Dec 2016 | $6.20 M(-50.7%) | $6.20 M(-52.4%) |
| Sept 2016 | - | $13.02 M(-1.7%) |
| June 2016 | - | $13.24 M(-6.8%) |
| Mar 2016 | - | $14.21 M(+23.3%) |
| Dec 2015 | $12.56 M(+0.7%) | - |
| Oct 2015 | - | $11.52 M(+2.7%) |
| July 2015 | - | $11.22 M(-10.1%) |
| Apr 2015 | $12.48 M(+18.4%) | $12.48 M(+15.2%) |
| Jan 2015 | - | $10.83 M(-6.9%) |
| Oct 2014 | - | $11.64 M(+18.0%) |
| July 2014 | - | $9.86 M(-6.5%) |
| Apr 2014 | $10.54 M(+112.6%) | $10.54 M(+190.0%) |
| Jan 2014 | - | $3.64 M(+140.9%) |
| Oct 2013 | - | $1.51 M(-68.3%) |
| July 2013 | - | $4.76 M(-4.0%) |
| Apr 2013 | $4.96 M(+10.5%) | $4.96 M(+6.8%) |
| Jan 2013 | - | $4.64 M(+29.0%) |
| Oct 2012 | - | $3.60 M(-37.6%) |
| July 2012 | - | $5.77 M(+28.5%) |
| Apr 2012 | $4.49 M | $4.49 M(-33.6%) |
| Jan 2012 | - | $6.76 M(-18.3%) |
| Oct 2011 | - | $8.27 M(+6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| July 2011 | - | $7.79 M(+17.3%) |
| Apr 2011 | $6.65 M(+374.1%) | $6.65 M(+77.4%) |
| Jan 2011 | - | $3.75 M(+155.6%) |
| Oct 2010 | - | $1.47 M(+14.5%) |
| July 2010 | - | $1.28 M(-8.7%) |
| Apr 2010 | $1.40 M(+99.9%) | $1.40 M(+16.9%) |
| Jan 2010 | - | $1.20 M(-27.4%) |
| Oct 2009 | - | $1.65 M(+190.4%) |
| July 2009 | - | $568.80 K(-18.9%) |
| Apr 2009 | $701.50 K(-12.8%) | $701.50 K(-60.9%) |
| Jan 2009 | - | $1.79 M(+2.6%) |
| Oct 2008 | - | $1.75 M(+4.0%) |
| July 2008 | - | $1.68 M(+108.6%) |
| Apr 2008 | $804.80 K(-56.4%) | $804.80 K(-67.3%) |
| Jan 2008 | - | $2.46 M(-5.3%) |
| Oct 2007 | - | $2.60 M(+9.5%) |
| July 2007 | - | $2.37 M(+28.5%) |
| Apr 2007 | $1.85 M(+334.7%) | $1.85 M(+16.8%) |
| Jan 2007 | - | $1.58 M(+41.1%) |
| Oct 2006 | - | $1.12 M(+32.5%) |
| July 2006 | - | $845.10 K(+99.0%) |
| Apr 2006 | $424.60 K(+35.3%) | $424.60 K(+29.2%) |
| Jan 2006 | - | $328.70 K(+42.5%) |
| Oct 2005 | - | $230.60 K(+142.5%) |
| July 2005 | - | $95.10 K(-69.7%) |
| Apr 2005 | $313.90 K(+6.9%) | $313.90 K(-13.2%) |
| Jan 2005 | - | $361.50 K(-14.0%) |
| Oct 2004 | - | $420.40 K(+23.6%) |
| July 2004 | - | $340.00 K(+15.8%) |
| Apr 2004 | $293.70 K(+1925.5%) | $293.70 K(-12.0%) |
| Jan 2004 | - | $333.80 K(+544.4%) |
| Oct 2003 | - | $51.80 K(-95.1%) |
| July 2003 | - | $1.07 M(+7252.4%) |
| Apr 2003 | $14.50 K(-91.9%) | $14.50 K(-82.2%) |
| Jan 2003 | - | $81.50 K(-28.1%) |
| Oct 2002 | - | $113.40 K(-14.2%) |
| July 2002 | - | $132.10 K(-26.2%) |
| Apr 2002 | $179.10 K(-48.0%) | $179.10 K(-55.0%) |
| Jan 2002 | - | $398.10 K(+14.0%) |
| Oct 2001 | - | $349.30 K(-11.1%) |
| July 2001 | - | $392.70 K(+14.1%) |
| Apr 2001 | $344.10 K(-0.4%) | $344.10 K(+16.6%) |
| Jan 2001 | - | $295.20 K(-0.5%) |
| Oct 2000 | - | $296.60 K(-12.3%) |
| July 2000 | - | $338.30 K(-2.1%) |
| Apr 2000 | $345.40 K(-42.4%) | $345.40 K(-42.4%) |
| Jan 2000 | - | $600.00 K(0.0%) |
| Oct 1999 | - | $600.00 K(0.0%) |
| July 1999 | - | $600.00 K |
| Apr 1999 | $600.00 K(-5.4%) | - |
| Apr 1998 | $634.40 K(+5.6%) | - |
| Apr 1997 | $600.70 K(-39.4%) | - |
| Apr 1996 | $991.50 K | - |
FAQ
- What is Tenax Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Tenax Therapeutics?
- What is Tenax Therapeutics annual total liabilities year-on-year change?
- What is Tenax Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Tenax Therapeutics?
- What is Tenax Therapeutics quarterly total liabilities year-on-year change?
What is Tenax Therapeutics annual total liabilities?
The current annual total liabilities of TENX is $3.59 M
What is the all time high annual total liabilities for Tenax Therapeutics?
Tenax Therapeutics all-time high annual total liabilities is $12.56 M
What is Tenax Therapeutics annual total liabilities year-on-year change?
Over the past year, TENX annual total liabilities has changed by +$1.67 M (+87.58%)
What is Tenax Therapeutics quarterly total liabilities?
The current quarterly total liabilities of TENX is $2.56 M
What is the all time high quarterly total liabilities for Tenax Therapeutics?
Tenax Therapeutics all-time high quarterly total liabilities is $14.21 M
What is Tenax Therapeutics quarterly total liabilities year-on-year change?
Over the past year, TENX quarterly total liabilities has changed by +$1.96 M (+325.39%)